Piper Sandler Raises Globe Life (GL) Price Target to $200

Font: Financial Modeling Prep  • Jul 15, 2026

Piper Sandler Raises Price Target for Globe Life (NYSE: GL) Amid Strong Performance

• Piper Sandler has increased its price target for Globe Life (NYSE: GL) to $200.00, maintaining an "Overweight" rating, reflecting confidence in the insurance stock.
• Globe Life has demonstrated strong market performance, with its shares gaining 48.7% over the past year, outperforming the S&P 500 and key competitors.
• The company exhibits solid operational results, including 12% growth in operating EPS, 58% acceleration in health sales, and robust cash generation, projecting up to $700.00 million in excess cash flow by 2026.

Analyst firm Piper Sandler increases its price target for Globe Life (NYSE: GL) to $200.00, maintaining an "Overweight" rating. Globe Life is an insurance holding company providing life and supplemental health insurance. The new target suggests confidence in the stock, which was trading at $178.99 when the rating was issued.

The firm's positive rating reflects Globe Life's strong market performance. As highlighted by Zacks Investment Research, Globe Life's shares have gained 48.7% over the past year. This growth surpasses its industry, its sector, and the S&P 500 composite, along with competitors like Aflac Incorporated (NYSE: AFL) and Unum Group (NYSE: UNM).

This performance is driven by solid operational results. The company reports a 12% growth in operating earnings per share (EPS). Its health sales have accelerated by 58%, and life insurance sales show increases across all its distribution channels, indicating broad-based strength in its business.

Globe Life also demonstrates a commitment to shareholder returns and strong cash generation. The company has returned $225.00 million to its shareholders. It also projects an excess cash flow between $650.00 million and $700.00 million for 2026, signaling a healthy financial position for the future.

Other analyses support this optimistic view. Zacks Investment Research notes Globe Life's high Return on Equity (ROE), a key metric showing how effectively a company generates profit from shareholder money. This, combined with a strong cash profile, makes it an attractive stock for some investors.